Evaluation of Clinical, Morphological and Pathohistological Characteristics of Thymomas - Our Ten Year Experience

  • Aleksandra Lovrenski Institute for pulmonary diseases of Vojvodina Medical Faculty Novi Sad
  • Dragana Tegeltija
  • Ivana Jeličić
  • Milorad Bijelović
  • Dejan Đurić
  • Milana Panjković
Keywords: Thymoma, Neoplasms,

Abstract


Background: Thymomas are rare neoplasms arising from tissue elements of the thymus. The objective of the study was to analyse clinical characteristics of patients with thymoma, as well as morphological and patohistological features of neoplasms.

Methods: Retrospectively we studied 41 medical records and patohistological material of patients reffered to the Institute of  pulmonary diseases of Vojvodina between the January of 2005 and December of 2014.

Results: Patient age at presentation ranged from 19 to 77 years. A slight female preponderance was detected, with 24 (58,5%) females and 17 (41,5%) males being affected. All types of thymoma more often occured in males, accept subtype B1. Patients with type A thymoma and subtype B1 were mainly asymptomatic, while patients with subtype B2 and type AB presented with dyspnea, dysphagia, pain and cough. Myasthenia gravis often was associated with type A (40%). The most common histologic type was subtype B1. 23 (56%) patients had a tumor diameter between 5 and 10 cm. Five patients had malignant thymoma, and the most common types of thymoma that showed signs of capsula invasion or pleural and pericardial implants were type AB (60%) and subtype B2 (50%). Biopsies of suspected tissue were obtained through a sternotomy, video-assisted thoracoscopy surgery, and video-assisted mini thoracotomy, and after setting a diagnosis on ex tempore analysis, the lesions were removed by thymectomy or extirpation of the tumor mass.

Conclusion: Thymomas have variable clinical presentations. Clinical outcome correlates with histological type, size and clinical stage, as well as the ability to achieve complete tumor resection.

Author Biographies

Aleksandra Lovrenski, Institute for pulmonary diseases of Vojvodina Medical Faculty Novi Sad
Dragana Tegeltija
Ivana Jeličić
Milorad Bijelović
Dejan Đurić
Milana Panjković

References

Cheuk W, Chan JKC. Tumors of the thymus. In: Fletcher C (Ed): Diagnostic Histopathology of Tumors (4th Edn). Churchill Livingstone, Inc. 2013, pp 1315-63.

Scorsetti M, Leo F, Trama A, D’Angelillo R, Serpico D, Macerelli M, Garassino MC. Thymoma and thymic carcinomas. Critical Reviews in Oncology/Hematology 2016;99:332-350. doi:10.1016/j.critrevonc.2016.01.012.

Hon C, Chui W, Cheng L, Shek TW, Jones BM, Au WY. Thymoma associated with keratoconjunctivitis, lichen planus, hypogammaglobinemia, and absent circulating B cells. Journal of Clinical Oncology 2006;24(18):2960-2961. doi:10.1200/jco.2005.04.3133.

Miyakis S, Pefanis A, Passam FH, Christodulakis GR, Roussou PA, Mountokalakis TD. Thymoma with immunodeficiency (Good's syndrome): Review of the literature apropos three cases. Scandinavian Journal of Infectious Diseases 2006;38(4):314-320. doi:10.1080/00365540500372663.

Moran CA, Weissferdt A. Staging of thymic epithelial neoplasms: Thymoma and thymic carcinoma. Pathology - Research and Practice 2015;211(1):2-11. doi:10.1016/j.prp.2014.06.007.

Skeie GO, Apostolski S, Evoli A, Gilhus NE, Hart IK, Harms L, Horge HW. Guidelines for the treatment of autoimmune neuromuscular transmission disorders. European Journal of Neurology 2006;13(7):691-699. doi:10.1111/j.1468-1331.2006.01476.x.

Hamaji M, Burt BM. Long-Term Outcomes of Surgical and Nonsurgical Management of Stage IV Thymoma: A Population-Based Analysis of 282 Patients. Seminars in Thoracic and Cardiovascular Surgery 2015;27(1):1-3. doi:10.1053/j.semtcvs.2015.02.005.

Muller-Hermelink HK, Engel P, Kuo TT, Ströbel P, Marx A, Harriset et al. Tumours of the thymus. In: Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC., editors. Tumours of the lung, pleura, thymus, and heart: World Health Organization Classification of Tumours. Lyon, France: IARC Press. 2015. pp 146-71.

Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer 1981;48(11):2485-2492. doi:10.1002/1097-0142(19811201)48:11<2485::aid-cncr2820481123>3.0.co;2-r.

Hazzard C, Kaufman A, Flores R. Mediastinal Tumors. In: IASLC Thoracic Oncology. 2018. pp 550-4.e1. (Second Edition).

Gilhus NE, Verschuuren JJ. Myasthenia gravis: subgroup classification and therapeutic strategies. The Lancet Neurology 2015;14(10):1023-1036. doi:10.1016/s1474-4422(15)00145-3.

Meriggioli MN, Sanders DB. Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. The Lancet Neurology 2009;8(5):475-490. doi:10.1016/s1474-4422(09)70063-8.

Yu L, Zhang X, Ma S, Li F, Zhang Y. Thoracoscopic Thymectomy for Myasthenia Gravis With and Without Thymoma: A Single-Center Experience. Annals of Thoracic Surgery 2012;93(1):240-244. doi:10.1016/j.athoracsur.2011.04.043.

Alexiev BA, Drachenberg CB, Burke AP. Thymomas: a cytological and immunohistochemical study, with emphasis on lymphoid and neuroendocrine markers. Diagnostic Pathology 2007;2(1):13. doi:10.1186/1746-1596-2-13.

Safieddine N, Liu G, Cuningham K, Ming T, Hwang D, Brade A, Waddell T. Prognostic Factors for Cure, Recurrence and Long-Term Survival After Surgical Resection of Thymoma. Journal of Thoracic Oncology 2014;9(7):1018-1022. doi:10.1097/jto.0000000000000215.

Qu Y, Liu G, Shi H, Liao M, Yang G, Tian Z. Preoperative CT Findings of Thymoma are Correlated with Postoperative Masaoka Clinical Stage. Academic Radiology 2013;20(1):66-72. doi:10.1016/j.acra.2012.08.002.

Zakowski MF, Huang J, Bramlage MP. The Role of Fine Needle Aspiration Cytology in the Diagnosis and Management of Thymic Neoplasia. Journal of Thoracic Oncology 2010;5(10):281-285. doi:10.1097/jto.0b013e3181f23e19.

Cheng Y, Kao E, Chou S. Videothoracoscopic resection of stage II thymoma: prospective comparison of the results between thoracoscopy and open methods. Chest 2005;128(4):3010-3012. doi:10.1378/chest.128.4.3010.

Iablonski PK, Pishchik, Nuraliev SM. Comparative assessment of the effectiveness of traditional and videothoracoscopic thymectomies in complex treatment of myasthenic thymomas. Vestn Khir Im II Grek 2005 164:38–42.

Kondo K, Monden Y. Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan. Annals of Thoracic Surgery 2003;76(3):878-884. doi:10.1016/s0003-4975(03)00555-1.

Wright CD, Choi NC, Wain JC, Mathisen DJ, Lynch TJ, Fidias P. Induction Chemoradiotherapy Followed by Resection for Locally Advanced Masaoka Stage III and IVA Thymic Tumors. Annals of Thoracic Surgery 2008;85(2):385-389. doi:10.1016/j.athoracsur.2007.08.051.

Zhou D, Deng X, Liu Q, Zheng H, Min J, Dai J. The Effectiveness of Postoperative Radiotherapy in Patients With Completely Resected Thymoma: A Meta-Analysis. The Annals of Thoracic Surgery 2016;101(1):305-310. doi:10.1016/j.athoracsur.2015.06.034.

Suster S, Moran CA. Mini-Symposium: Pathology of the mediastinum. Problems in the classification of thymoma. Diagnostic Histopathology 2010;16(5):221-227. doi:10.1016/j.mpdhp.2010.03.004.

Wright CD, Wain JC, Wong DR, Donahue DM, Gaissert HA, Grillo HC, Mathisen DJ. Predictors of recurrence in thymic tumors: Importance of invasion, World Health Organization histology, and size. Journal of Thoracic and Cardiovascular Surgery 2005;130(5):1413-1421. doi:10.1016/j.jtcvs.2005.07.026.

Published
2018/02/09
Section
Original Scientific Paper